GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 767 filers reported holding GLAXOSMITHKLINE PLC in Q1 2021. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $282,000 | -0.4% | 7,900 | +2.6% | 0.02% | -5.9% |
| Q4 2020 | $283,000 | -1.0% | 7,700 | +1.3% | 0.02% | -5.6% |
| Q3 2020 | $286,000 | -4.0% | 7,600 | +4.1% | 0.02% | -14.3% |
| Q2 2020 | $298,000 | -2.9% | 7,300 | -9.9% | 0.02% | -16.0% |
| Q1 2020 | $307,000 | -75.9% | 8,100 | -70.1% | 0.02% | -70.6% |
| Q4 2019 | $1,273,000 | +6.5% | 27,100 | -3.2% | 0.08% | 0.0% |
| Q3 2019 | $1,195,000 | +9.7% | 28,000 | +2.9% | 0.08% | +7.6% |
| Q2 2019 | $1,089,000 | -10.7% | 27,200 | -6.8% | 0.08% | -14.1% |
| Q1 2019 | $1,220,000 | +8.3% | 29,200 | -1.0% | 0.09% | -1.1% |
| Q4 2018 | $1,127,000 | +20.9% | 29,500 | +27.2% | 0.09% | +38.8% |
| Q3 2018 | $932,000 | -4.0% | 23,200 | -3.7% | 0.07% | -9.5% |
| Q2 2018 | $971,000 | -5.2% | 24,100 | -8.0% | 0.07% | -5.1% |
| Q1 2018 | $1,024,000 | +9.8% | 26,200 | -0.4% | 0.08% | +13.0% |
| Q4 2017 | $933,000 | +52.2% | 26,300 | +74.2% | 0.07% | +46.8% |
| Q3 2017 | $613,000 | +6.1% | 15,100 | +12.7% | 0.05% | +4.4% |
| Q2 2017 | $578,000 | +10.5% | 13,401 | +8.1% | 0.04% | +4.7% |
| Q1 2017 | $523,000 | -21.2% | 12,401 | -28.1% | 0.04% | -24.6% |
| Q4 2016 | $664,000 | -8.2% | 17,241 | +2.8% | 0.06% | -8.1% |
| Q3 2016 | $723,000 | +9.2% | 16,771 | +9.8% | 0.06% | +14.8% |
| Q2 2016 | $662,000 | +54.3% | 15,271 | +44.5% | 0.05% | +45.9% |
| Q1 2016 | $429,000 | +6.7% | 10,571 | +6.0% | 0.04% | +5.7% |
| Q4 2015 | $402,000 | -4.7% | 9,971 | -9.1% | 0.04% | -10.3% |
| Q3 2015 | $422,000 | -1.4% | 10,971 | +6.8% | 0.04% | +11.4% |
| Q2 2015 | $428,000 | -11.4% | 10,271 | -1.9% | 0.04% | -5.4% |
| Q1 2015 | $483,000 | -69.0% | 10,471 | -69.1% | 0.04% | -79.1% |
| Q3 2014 | $1,557,000 | -23.6% | 33,871 | -11.3% | 0.18% | -23.7% |
| Q1 2014 | $2,039,000 | +61.3% | 38,171 | +61.3% | 0.23% | +57.8% |
| Q4 2013 | $1,264,000 | +72.9% | 23,671 | +62.5% | 0.15% | +50.0% |
| Q3 2013 | $731,000 | – | 14,571 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |